179 related articles for article (PubMed ID: 23596350)
1. Lithium and neuroprotection: translational evidence and implications for the treatment of neuropsychiatric disorders.
Diniz BS; Machado-Vieira R; Forlenza OV
Neuropsychiatr Dis Treat; 2013; 9():493-500. PubMed ID: 23596350
[TBL] [Abstract][Full Text] [Related]
2. Lithium, a Treatment Option for Alzheimer's Disease? A Review of Existing Evidence and Discussion on Future Perspectives.
Guilliot S; Gauthier S; Touchon J; Soto ME
J Alzheimers Dis; 2023; 96(2):473-482. PubMed ID: 37781804
[TBL] [Abstract][Full Text] [Related]
3. Nanolithium, a New Treatment Approach to Alzheimer's Disease: A Review of Existing Evidence and Clinical Perspectives.
Guilliot S; Wilson EN; Touchon J; Soto ME
J Prev Alzheimers Dis; 2024; 11(2):428-434. PubMed ID: 38374749
[TBL] [Abstract][Full Text] [Related]
4. Lithium and its effects: does dose matter?
Manchia M; Paribello P; Pinna M; Steardo L; Carpiniello B; Pinna F; Pisanu C; Squassina A; Hajek T
Int J Bipolar Disord; 2024 Jun; 12(1):23. PubMed ID: 38914810
[TBL] [Abstract][Full Text] [Related]
5. An Overview of the Neurotrophic and Neuroprotective Properties of the Psychoactive Drug Lithium as an Autophagy Modulator in Neurodegenerative Conditions.
Singh A; Arora S; Chavan M; Shahbaz S; Jabeen H
Cureus; 2023 Aug; 15(8):e44051. PubMed ID: 37746513
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective effects of lithium: implications for the treatment of Alzheimer's disease and related neurodegenerative disorders.
Forlenza OV; De-Paula VJ; Diniz BS
ACS Chem Neurosci; 2014 Jun; 5(6):443-50. PubMed ID: 24766396
[TBL] [Abstract][Full Text] [Related]
7. A new avenue for lithium: intervention in traumatic brain injury.
Leeds PR; Yu F; Wang Z; Chiu CT; Zhang Y; Leng Y; Linares GR; Chuang DM
ACS Chem Neurosci; 2014 Jun; 5(6):422-33. PubMed ID: 24697257
[TBL] [Abstract][Full Text] [Related]
8. Lithium as a Treatment for Alzheimer's Disease: A Systematic Review and Meta-Analysis.
Matsunaga S; Kishi T; Annas P; Basun H; Hampel H; Iwata N
J Alzheimers Dis; 2015; 48(2):403-10. PubMed ID: 26402004
[TBL] [Abstract][Full Text] [Related]
9. Beneficial synergistic effects of microdose lithium with pyrroloquinoline quinone in an Alzheimer's disease mouse model.
Zhao L; Gong N; Liu M; Pan X; Sang S; Sun X; Yu Z; Fang Q; Zhao N; Fei G; Jin L; Zhong C; Xu T
Neurobiol Aging; 2014 Dec; 35(12):2736-2745. PubMed ID: 25018109
[TBL] [Abstract][Full Text] [Related]
10. GSK-3β, a pivotal kinase in Alzheimer disease.
Llorens-Martín M; Jurado J; Hernández F; Avila J
Front Mol Neurosci; 2014; 7():46. PubMed ID: 24904272
[TBL] [Abstract][Full Text] [Related]
11. Glycogen synthase kinase-3 inhibitors: Rescuers of cognitive impairments.
King MK; Pardo M; Cheng Y; Downey K; Jope RS; Beurel E
Pharmacol Ther; 2014 Jan; 141(1):1-12. PubMed ID: 23916593
[TBL] [Abstract][Full Text] [Related]
12. New Advances in the Pharmacology and Toxicology of Lithium: A Neurobiologically Oriented Overview.
Bortolozzi A; Fico G; Berk M; Solmi M; Fornaro M; Quevedo J; Zarate CA; Kessing LV; Vieta E; Carvalho AF
Pharmacol Rev; 2024 May; 76(3):323-357. PubMed ID: 38697859
[TBL] [Abstract][Full Text] [Related]
13. Diet and lifestyle impact the development and progression of Alzheimer's dementia.
Arora S; Santiago JA; Bernstein M; Potashkin JA
Front Nutr; 2023; 10():1213223. PubMed ID: 37457976
[TBL] [Abstract][Full Text] [Related]
14. A cross-sectional study of cognitive performance in bipolar disorder across the lifespan: the cog-BD project.
Jones BDM; Fernandes BS; Husain MI; Ortiz A; Rajji TK; Blumberger DM; Butters MA; Gildengers AG; Shablinski T; Voineskos A; Mulsant BH
Psychol Med; 2023 Oct; 53(13):6316-6324. PubMed ID: 36464659
[TBL] [Abstract][Full Text] [Related]
15. Soilless biofortification, bioaccessibility, and bioavailability: Signposts on the path to personalized nutrition.
Renna M; D'Imperio M; Maggi S; Serio F
Front Nutr; 2022; 9():966018. PubMed ID: 36267903
[TBL] [Abstract][Full Text] [Related]
16. Mental health care for older adults: recent advances and new directions in clinical practice and research.
Reynolds CF; Jeste DV; Sachdev PS; Blazer DG
World Psychiatry; 2022 Oct; 21(3):336-363. PubMed ID: 36073714
[TBL] [Abstract][Full Text] [Related]
17. Lithium treatment and human hippocampal neurogenesis.
Palmos AB; Duarte RRR; Smeeth DM; Hedges EC; Nixon DF; Thuret S; Powell TR
Transl Psychiatry; 2021 Oct; 11(1):555. PubMed ID: 34718328
[TBL] [Abstract][Full Text] [Related]
18. Translational evidence for lithium-induced brain plasticity and neuroprotection in the treatment of neuropsychiatric disorders.
Puglisi-Allegra S; Ruggieri S; Fornai F
Transl Psychiatry; 2021 Jul; 11(1):366. PubMed ID: 34226487
[TBL] [Abstract][Full Text] [Related]
19. Lithium inhibits oxidative stress-induced neuronal senescence through miR-34a.
Tufekci KU; Alural B; Tarakcioglu E; San T; Genc S
Mol Biol Rep; 2021 May; 48(5):4171-4180. PubMed ID: 34052966
[TBL] [Abstract][Full Text] [Related]
20. Increased Risk of Dementia Among Veterans With Bipolar Disorder or Schizophrenia Receiving Care in the VA Health System.
Ahearn EP; Szymanski BR; Chen P; Sajatovic M; Katz IR; McCarthy JF
Psychiatr Serv; 2020 Oct; 71(10):998-1004. PubMed ID: 32517643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
